Mitochondrial Dysfunction and Multiple Sclerosis
AbstractIn recent years, several studies have examined the potential associations between mitochondrial dysfunction and neurodegenerative diseases such as multiple sclerosis (MS), Parkinson’s disease and Alzheimer’s disease. In MS, neurological disability results from inflammation, demyelination, and ultimately, axonal damage within the central nervous system. The sustained inflammatory phase of the disease leads to ion channel changes and chronic oxidative stress. Several independent investigations have demonstrated mitochondrial respiratory chain deficiency in MS, as well as abnormalities in mitochondrial transport. These processes create an energy imbalance and contribute to a parallel process of progressive neurodegeneration and irreversible disability. The potential roles of mitochondria in neurodegeneration are reviewed. An overview of mitochondrial diseases that may overlap with MS are also discussed, as well as possible therapeutic targets for the treatment of MS and other neurodegenerative conditions. View Full-Text
Share & Cite This Article
Barcelos, I.P.; Troxell, R.M.; Graves, J.S. Mitochondrial Dysfunction and Multiple Sclerosis. Biology 2019, 8, 37.
Barcelos IP, Troxell RM, Graves JS. Mitochondrial Dysfunction and Multiple Sclerosis. Biology. 2019; 8(2):37.Chicago/Turabian Style
Barcelos, Isabella P.; Troxell, Regina M.; Graves, Jennifer S. 2019. "Mitochondrial Dysfunction and Multiple Sclerosis." Biology 8, no. 2: 37.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.